期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Ginkgo biloba leaf extract improves the cognitive abilities of rats with D-galactose induced dementia 被引量:6
1
作者 Nuan Wang Xianming Chen +2 位作者 Deqin Geng hongli huang Hao Zhou 《The Journal of Biomedical Research》 CAS 2013年第1期29-36,共8页
Standardized Ginkgo biloba leaf extract has been used in clinical trials for its beneficial effects on brain func- tions, particularly in dementia. Substantial experimental evidences indicated that Ginkgo biloba leaf ... Standardized Ginkgo biloba leaf extract has been used in clinical trials for its beneficial effects on brain func- tions, particularly in dementia. Substantial experimental evidences indicated that Ginkgo biloba leaf extract (EGB) protected neuronal cells from a variety of insults. We investigated the effect of EGB on cognitive ability and protein kinase B (PKB) activity in hippocampal neuronal cells of dementia model rats. Rats received an intra- peritoneal injection of D-galactose to induce dementia. Forty-eight Spraque-Dawley rats were randomly divided into six groups, including the control group, D-galactose group (Gal), low-dose EGB group (EGB-L), mid-dose EGB group (EGB-M), high-dose EGB group (EGB-H) and treatment group. The EGB-L, EGB-M and EGB-H groups were administered with EGB and D-galactose simultaneously. Y-maze, cresyl violet staining, TUNEL assays and immunohistochemistry staining were performed to detect learning and memory abilities, morpho- logical changes in the hippocampus, neuronal apoptosis and the expressing level of phospho-PKB, respectively. Rats in the Gal group showed decreased abilities of learning and memory, and hippocampal pyramidal cell layer was damaged, while EGB administration improved learning and memory abilities. The Gal group exhibited many stained, condensed nuclei and micronuclei, either isolated or within the cytoplasm of cells (39.5 ± 1.4). Apoptotic cells decreased in the groups of EGB-L (35.9±0.9), EGB-M (16.8± 1.0) and EGB-H (10.1±0.8), and there were statistical significances compared with the Gal group. Immunoreactivity of phospho-PKB was localized diffusely throughout the cytosol of cells in all groups, while the immunoreactivity of the Gal group was weak. EGB signifi- cantly attenuated learning and memory impairment in a dose-dependent manner, while it could decrease the nmber of TUNEL-positive cells, and increase the activity of PKB. Our results demonstrated that EGB attenuated memory impairment and cell apoptosis in galactose-induced dementia model rats by activating PKB. 展开更多
关键词 dementia model D-GALACTOSE Ginkgo biloba extract APOPTOSIS protein kinase B (PKB) cognitive ability
下载PDF
信迪利单抗联合瑞戈非尼治疗晚期结直肠癌的疗效与安全性分析
2
作者 梁文龙 曹杰 +5 位作者 黄庆 林泳 黄红丽 杨平 李冠炜 胡鹤 《中华消化病与影像杂志(电子版)》 2023年第6期409-413,共5页
目的探究免疫检查点抑制剂信迪利单抗联合瑞戈非尼治疗晚期结直肠癌(CRC)患者疗效与安全性的影响。方法前瞻性选取2020年1月至2022年1月在广州市第一人民医院接受治疗的晚期CRC患者90例,按照随机数字表法分为观察组和对照组各45例。对... 目的探究免疫检查点抑制剂信迪利单抗联合瑞戈非尼治疗晚期结直肠癌(CRC)患者疗效与安全性的影响。方法前瞻性选取2020年1月至2022年1月在广州市第一人民医院接受治疗的晚期CRC患者90例,按照随机数字表法分为观察组和对照组各45例。对照组口服瑞戈非尼,观察组在对照组基础上加用信迪利单抗注射液。比较两组临床疗效、肿瘤标志物及免疫功能水平、生存时间及不良反应发生情况。结果治疗后,观察组CRC患者的客观缓解率为53.33%、疾病控制率为80.00%,对照组分别为20.00%、60.00%(P<0.05);两组糖类抗原(CA199)、细胞角蛋白19片段抗原21-1(CYFRA21-1)、癌胚抗原(CEA)均下降,且观察组比对照组更低(P<0.05);两组细胞毒性T细胞(CD8^(+))占比均下降,两组辅助性T细胞(CD4^(+))占比、CD4^(+)/CD8^(+)比值均上升,而且观察组CD4^(+)占比、CD4^(+)/CD8^(+)比值比对照组更高(P<0.05),CD8^(+)占比比对照组更低(P>0.05)。观察组总生存期(P=0.040)和无进展生存期(P=0.046)均比对照组长;观察组比对照组出现不良反应概率更低(64.44%比62.22%,P>0.05)。结论免疫检查点抑制剂信迪利单抗联合瑞戈非尼在晚期CRC的治疗中有较好的应用效果和安全性,延长了生存时间,减轻肿瘤给患者带来的痛苦。 展开更多
关键词 结直肠癌 免疫检查点抑制剂 临床疗效 生存分析 安全性
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部